PAR 1.61% 30.5¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-54

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    They will still definitely go for the peer review based on the announcement. PAR do have some significant results from 56 days and 6 months, so that will all go into the peer review, along with some of the other data I would think.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
-0.005(1.61%)
Mkt cap ! $108.4M
Open High Low Value Volume
31.0¢ 31.5¢ 30.5¢ $83.98K 268.9K

Buyers (Bids)

No. Vol. Price($)
6 23546 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 50509 2
View Market Depth
Last trade - 10.57am 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.